Table 2.
Patient demographics and characteristics
| Characteristic | n (%) |
|---|---|
| Number of patients | 24 |
| Total number of courses | 64 |
| Number courses delivered per patient | |
| Median | 2 |
| Range | 1–6 |
| Patients receiving more than or equal to three cycles of therapy | 9 |
| Sex | |
| Male | 13 (54) |
| Female | 11 (46) |
| Age | |
| Median (in years) | 54 |
| Range (in years) | 20–75 |
| ECOG performance statusa | |
| 0 | 5 |
| 1 | 17 |
| 2 | 2 |
| Previous treatment | |
| Patients with prior chemotherapy treatments | 21 (88) |
| Median (range) of chemotherapy treatments | 2 (0–4) |
| No prior therapy (including targeted therapy, chemotherapy and radiotherapy) | 2 |
| Prior radiotherapy | 15 (63) |
| Tumor type | |
| Melanoma | 4 |
| Upper GI tractb | 3 |
| Sarcomac | 3 |
| Colon | 2 |
| Head and neck | 2 |
| Pancreatic cancer | 2 |
| Otherd | 7 |
ECOG Eastern Cooperative Oncology Group
Includes one each esophageal, gastroesophageal and gastric carcinomas
Includes one each of angiosarcoma, Ewing's sarcoma and leiomyosarcoma
Other tumor types include one each of: adenocarcinoma of the breast, astrocytoma, germinoma, endometrial, ovarian, non-small cell lung, and renal cell carcinoma